Company profile: IntelGenx
1.1 - Company Overview
Company description
- Provider of oral drug delivery technologies focused on developing and manufacturing pharmaceutical oral films, transmucosal films, and transdermal patches. Solutions include VersaFilm and DisinteQ for rapidly dissolving oral films, VetaFilm for veterinary films for pets, Transmucosal Films for buccal/sublingual absorption, and VevaDerm for extended-release patches.
Products and services
- VersaFilm: IntelGenX engineers a rapid-dissolving platform for creating oral films that dissolve quickly, enabling water-free dosing and swift in-mouth dispersion for drug administration
- Transmucosal Films: IntelGenX produces buccal and sublingual films that enhance drug absorption and accelerate onset of action while minimizing side effects, built for mucosal delivery
- Oral Films: IntelGenX architects thin-film oral films that dissolve in the mouth, delivering medication without needing water
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IntelGenx
Kaleo
HQ: United States
Website
- Description: Provider of specialty pharmaceutical combination drug/device products and auto-injectors, including the Aerio gas-powered auto-injector platform (single, dual container, dual chamber); AUVI-Q and ALLERJECT epinephrine devices for severe allergic reactions; Naloxone Auto-Injector 10 mg for military and chemical incident responders; Pralidoxime Chloride Auto-Injector; and a patient assistance program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kaleo company profile →
Windgap Medical
HQ: United States
Website
- Description: Provider of drug delivery medical devices for severe allergies and other therapeutic areas, including ANDIPen, a wet/dry dual-chamber autoinjector with improved temperature resilience and extended shelf life, and LVDC for large-volume dual-chamber injections of high-viscosity or difficult-to-mix medications with IM and SubQ options. Develops platforms to stabilize heat- and time-sensitive liquids and collaborates with pharmaceutical partners to commercialize its technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Windgap Medical company profile →
Lypro Bio
HQ: United States
Website
- Description: Provider of NanoDisk drug delivery technology to increase solubility and bioavailability of hydrophobic drugs, with applications in cancer (curcumin and all-trans retinoic acid for glioblastoma multiforme and mantle cell lymphoma), infectious diseases (amphotericin B for Leishmania major and Aspergillosis), and neurodegenerative disease research; also offers Ambigent, an antifungal reagent for high-value cell cultures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lypro Bio company profile →
Nemera
HQ: France
Website
- Description: Provider of design, development and manufacturing of drug delivery solutions for pharmaceutical, biotechnology and generics industries, covering parenteral, nasal, buccal, auricular, ophthalmic, pulmonary, dermal and transdermal modes of delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nemera company profile →
Travanti Pharma
HQ: United States
Website
- Description: Provider of innovative drug delivery platforms that improve the safety, compliance, effectiveness, and ease of administration of medications delivered into the body; designs, develops, and markets these platforms to enhance medication delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Travanti Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IntelGenx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IntelGenx
2.2 - Growth funds investing in similar companies to IntelGenx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IntelGenx
4.2 - Public trading comparable groups for IntelGenx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →